Biotechnology
Breaking News
Healthcare
Investing News
Market News
Technology
The Buzz
The Buzz TV
The Market Buzz
Top Videos
Video
“The Buzz” Show: Harpoon Therapeutics (NASDAQ: HARP) Interim Data From Multiple Myeloma Trial
FinancialBuzz.com’s latest The Buzz Show: Featuing Our Corporate News Recap on “Harpoon Therapeutics Shares Up 90% on Interim Data From Relapsed/Refractory Multiple Myeloma Trial” Harpoon Therapeutics, Inc. (NASDAQ: HARP), a...